| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Huang,Jing-Rong | Chairman | 57.60% | CELXPERT ENERGY CORPORATION |
| Lin,Jian-Yu | Director | 57.60% | CELXPERT ENERGY CORPORATION |
| Cai,Cheng-Yang | Director | 57.60% | CELXPERT ENERGY CORPORATION |
| Wang,Qiao-Pin | Director | 1.24% | |
| Lin,Yu-Xin | Independent Director | 0.00% | |
| Chen,Jia-Yu | Independent Director | 0.00% | |
| Li,Yi-Yu | Independent Director | 0.00% |
Change Company Name to KEELGOAL ENERGY CO., LTD.
2024/05/07
Change Person in Charge to Huang,Jing-Rong
2024/01/04
Change Capital to 500,000,000
2023/03/22
Change Company Name to RUITENG ENERGY CO., LTD. (FORMER NAME: RUITENG ENERGY CO., LTD.)
2022/05/31
Change Capital to 200,000,000
2022/05/31
Change Company Name to KEELGO ENERGY CO., LTD.
2021/09/28
Change Company Name to RUITENG ENERGY CO., LTD. (FORMER NAME: XUFA ENERGY CO., LTD.)
2021/09/28
Change Capital to 70,500,000
2021/09/28
Change Company Name to KEELGO ENERGY CO., LTD.
2020/12/01
Change Company Name to RUITENG ENERGY CO., LTD. (FORMER NAME: XUFA ENERGY CO., LTD.)
2020/12/01
Change Capital to 50,500,000
2020/12/01
Change Company Name to KEELGO ENERGY CO., LTD.
2020/02/19
Change Company Name to RUITENG ENERGY CO., LTD. (FORMER NAME: XUFA ENERGY CO., LTD.)
2020/02/19
Change Person in Charge to Huang,Shi-Ming
2020/02/19
Change Company Name to KEELGO ENERGY CO., LTD.
2019/09/30
Change Company Name to RUITENG ENERGY CO., LTD. (FORMER NAME: XUFA ENERGY CO., LTD.)
2019/09/30
Change Capital to 30,500,000
2019/09/30
Change Company Name to KEELGO ENERGY CO., LTD.
2019/02/11
Change Company Name to RUITENG ENERGY CO., LTD. (FORMER NAME: XUFA ENERGY CO., LTD.)
2019/02/11
Change Company Name to RUITENG ENERGY CO., LTD. (FORMER NAME: XUFA ENERGY CO., LTD.)
2019/01/09
Change Capital to 15,500,000
2019/01/09
Change Company Name to RUITENG ENERGY CO., LTD. (FORMER NAME: XUFA ENERGY CO., LTD.)
2018/12/14
Change Company Name to KEELGO ENERGY CO., LTD.
2018/12/14
Change Person in Charge to Huang,Zi-Ling
2018/12/14
下載完整報告查看完整數據
| 項目 | 2024 |
|---|---|
| Operating income | 52,587 |
| Operating cost | 9,232 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - |
| Operating gross profit (loss) | 43,355 |
| Unrealized profit (loss) on sales of goods | 0 |
| Realized profit (loss) on sales of goods | - |
| Operating gross profit (loss), net | 43,355 |
| Operating expenses | 29,656 |
| Other gain (loss), net | - |
| Operating profit (loss) | 13,699 |
| Non-operating income and expenses | 2,421 |
| Net profit (loss) before tax | 16,120 |
| Income tax expense (benefits) | 253 |
| Net profit (loss) of ongoing business for the current period | 15,867 |
| Profit (loss) of closed units | - |
| Profit (loss) of non-jointly controlled equity before merger | - |
| Net profit (loss) for the current period | 15,867 |
| Other comprehensive profit (loss), net | - |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - |
| Total comprehensive profit and loss for the current period | 15,867 |
| Net profit (loss) attributable to owners of parent company | - |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - |
| Net profit (loss) attributable to non-controlling interests | - |
| Comprehensive profit (loss) attributable to owners of parent company | - |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - |
| Comprehensive profit (loss) attributable to non-controlling interests | - |
| Basic earnings per share (yuan) | 1 |
| 項目 | 2024 |
|---|---|
| Net cash inflow (outflow) from operating activities | - |
| Net cash inflows (outflows) from investing activities | - |
| Net cash inflow (outflow) from financing activities | - |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | - |
| Increase (decrease) in cash and cash equivalents in the current period | - |
| Beginning balance of cash and cash equivalents | - |
| Ending balance of cash and cash equivalents | - |
| 項目 | 2024 |
|---|---|
| Current asset | 301,837 |
| Non-current asset | 21,592 |
| Total asset | 323,429 |
| Current liability | 146,192 |
| Non-current liability | 9,019 |
| Total liability | 155,211 |
| share capital | 131,000 |
| Equity - secruity token | 0 |
| capital reserve | 9,832 |
| retained earning | 27,386 |
| Other equity | 0 |
| Treasury stock | 0 |
| Total equity attributable to owners of parent company | - |
| Equity attributable to former owner of business combination under common control | 0 |
| Equity attributable to non-controlling interest before business merger under common control | 0 |
| Non-controlling interests | - |
| Total Equity | 168,218 |
| Share capital awaiting retirement (unit: share) | - |
| Issued shares of advance equity (unit: shares) | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 |
| Net asset value per share | 12 |
